検索
NovaBay Pharmaceuticals Inc
NBYウォッチリストに追加
1.950USD
0.0000.00%
終値 07/02, 13:00（ET）15分遅れの株価
68.61M時価総額
損失額直近12ヶ月PER
詳細情報 NovaBay Pharmaceuticals Inc 企業名
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
NovaBay Pharmaceuticals Incの企業情報
企業コードNBY
会社名NovaBay Pharmaceuticals Inc
上場日Oct 26, 2007
最高経営責任者「CEO」Kazley (Michael John)
従業員数14
証券種類Ordinary Share
決算期末Oct 26
本社所在地2000 Powell St Ste 1150
都市EMERYVILLE
証券取引所NASDAQ OMX – NASDAQ Basic Amex
国United States of America
郵便番号94608-1804
電話番号15108998800
ウェブサイトhttps://novabay.com/
企業コードNBY
上場日Oct 26, 2007
最高経営責任者「CEO」Kazley (Michael John)
NovaBay Pharmaceuticals Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
よくある質問
NovaBay Pharmaceuticals Incの上位5名の株主は誰ですか？
NovaBay Pharmaceuticals Incの上位5名の株主は以下のとおりです。Ms. Swan Sit
NovaBay Pharmaceuticals Inc（NBY）の株式を保有している機関の数はいくつですか？
2026Q1時点で、NovaBay Pharmaceuticals Incの株式を保有している機関は47社あり、保有株式の総市場価値は約1.80Mで、全体の6.77%を占めています。2025Q4と比較して、機関の持ち株は1464094.00増加しています。